BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Lenalidomide After Allo Transplant

Phase 1

Terminated

Conditions: Multiple Myeloma
Lymphoma

Interventions: Drug: Lenalidomide

First Posted Date: 2012-12-17

Last Posted Date: 2017-04-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 1

Registration Number: NCT01750762

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

Not Applicable

Completed

Conditions: Postmenopausal Women

Interventions: Other: soy nuts

First Posted Date: 2012-12-04

Last Posted Date: 2017-03-31

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 84

Registration Number: NCT01740076

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Early Phase 1

Completed

Conditions: Healthy

Interventions: Drug: isoquercetin or quercetin

First Posted Date: 2012-11-07

Last Posted Date: 2020-10-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 38

Registration Number: NCT01722669

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

Not Applicable

Completed

Conditions: HMG COA Reductase Inhibitor Adverse Reaction
Myopathy
Hypercholesterolemia

Interventions: Dietary Supplement: placebo
Dietary Supplement: ubiquinol
Drug: statin

First Posted Date: 2012-10-10

Last Posted Date: 2017-04-17

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 22

Registration Number: NCT01702987

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

Not Applicable

Completed

Conditions: Acute Respiratory Distress Syndrome

Interventions: Other: Esophageal-pressure guided mechanical ventilation
Other: High PEEP mechanical ventilation

First Posted Date: 2012-09-07

Last Posted Date: 2019-12-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 202

Registration Number: NCT01681225

Locations: 🇺🇸
University of California at San Diego, La Jolla, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Orlando Health, Orlando, Florida, United States

and more 11 locations

Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2012-09-05

Last Posted Date: 2015-11-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 70

Registration Number: NCT01678300

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Cisplatin
Drug: Cyclophosphamide
Drug: Doxorubicin

First Posted Date: 2012-08-22

Last Posted Date: 2024-10-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 118

Registration Number: NCT01670500

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 12 locations

High-Dose Deferoxamine in Intracerebral Hemorrhage

Phase 2

Terminated

Conditions: Intracerebral Hemorrhage

Interventions: Drug: Normal saline
Drug: Deferoxamine

First Posted Date: 2012-08-13

Last Posted Date: 2019-06-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 42

Registration Number: NCT01662895

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

and more 26 locations

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Phase 2

Completed

Conditions: Sialorrhea

Interventions: Drug: Placebo
Drug: Incobotulinum Toxin A

First Posted Date: 2012-07-30

Last Posted Date: 2017-03-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 10

Registration Number: NCT01653132

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: Transcranial Direct Current Stimulation (tDCS)

First Posted Date: 2012-07-02

Last Posted Date: 2019-01-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 14

Registration Number: NCT01632280

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy